Prime Medicine (PRME) Amortization - Intangibles (2023 - 2026)
Prime Medicine posted quarterly Amortization - Intangibles of $460000.0 for Q1 2026, up 35.69% year-on-year from $339000.0 in Q1 2025, and down 46.39% on a QoQ basis from $858000.0 in Q4 2025.
Prime Medicine (PRME) has 4 years of Amortization - Intangibles data on file, last reported at $460000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization - Intangibles rose 35.69% year-over-year to $460000.0; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (down 13.79% YoY), and the FY2025 full-year result was $2.5 million, down 29.31% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $460000.0, down from $858000.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $2.0 million in Q2 2023 and bottomed at $306000.0 in Q4 2024.
- The 4-year median for Amortization - Intangibles is $844000.0 (2024), against an average of $942083.3.
- The widest annual swing landed in 2024, when Amortization - Intangibles slumped 72.82%; it then surged 180.39% in 2025.
- A 4-year view of Amortization - Intangibles shows it stood at $1.1 million in 2023, then plunged by 72.82% to $306000.0 in 2024, then jumped by 180.39% to $858000.0 in 2025, then tumbled by 46.39% to $460000.0 in 2026.
- The last three Amortization - Intangibles figures came in at $460000.0 (Q1 2026), $858000.0 (Q4 2025), and $752000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Prime Medicine | 601.24 Mn | 601.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 460,000.00 |
| Dec 31, 2025 | 858,000.00 |
| Sep 30, 2025 | 752,000.00 |
| Jun 30, 2025 | 530,000.00 |
| Mar 31, 2025 | 339,000.00 |
| Dec 31, 2024 | 306,000.00 |
| Sep 30, 2024 | 885,000.00 |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 830,000.00 |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Jun 30, 2023 | 1.96 Mn |